Re: "Commentary" by Rothrock et al. "Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19"
- PMID: 35389575
- DOI: 10.1097/MJT.0000000000001465
Re: "Commentary" by Rothrock et al. "Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19"
Comment in
-
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19.Am J Ther. 2022 Feb 10;29(2):e237-e244. doi: 10.1097/MJT.0000000000001477. Am J Ther. 2022. PMID: 35389576 No abstract available.
Comment on
-
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19.Am J Ther. 2021 Dec 7;29(1):e87-e94. doi: 10.1097/MJT.0000000000001461. Am J Ther. 2021. PMID: 34994351 No abstract available.
References
-
- Rothrock SG, Weber KD, Giordano PA, et al. Meta-analyses do not establish improved mortality with ivermectin use in COVID-19. “Commentary”. Am J Ther. 2021.
-
- Bryant A, Lawrie TA, Dowswell T, et al. Ivermectin for prevention and treatment of covid-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Therap. 2021;28:e434–460.
-
- Bryant A, Lawrie TA, Fordham EJ. Ivermectin for prevention and treatment of cOVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Ther. 2021;2828:e434–e460.
-
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
-
- Popp M, Stegemann M, Metzendorf M-I, et al. Ivermectin for preventing and treating covid-19. Cochrane Database Syst Rev. 2021;7:CD015017.
Publication types
LinkOut - more resources
Full Text Sources